Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EEG Biomarker Development for Ketamine Administration

NCT07307768 is registered in ClinicalTrials.gov with Soterix Medical as lead sponsor.

NCT NCT07307768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07307768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EEG Biomarker Development for Ketamine Administration
Lead sponsor
Soterix Medical
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 20, 2025
Completion date
March 1, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression (trd)